SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 20.43%11.44B | 35.98%11.3B | 25.98%8.77B | 19.56%34.12B | 28.10%9.35B | 36.84%9.5B | 28.11%8.31B | -10.88%6.96B | 0.79%28.54B | -8.73%7.3B |
Operating revenue | 20.43%11.44B | 35.98%11.3B | 25.98%8.77B | 19.56%34.12B | 28.10%9.35B | 36.84%9.5B | 28.11%8.31B | -10.88%6.96B | 0.79%28.54B | -8.73%7.3B |
Cost of revenue | 16.70%2.17B | 20.07%2.17B | 2.88%1.67B | 6.82%7.08B | 15.50%1.79B | 17.79%1.86B | 26.35%1.81B | -21.50%1.63B | -9.34%6.63B | -24.49%1.55B |
Gross profit | 21.34%9.27B | 40.40%9.13B | 33.02%7.09B | 23.41%27.04B | 31.49%7.57B | 42.44%7.64B | 28.61%6.5B | -7.05%5.33B | 4.31%21.91B | -3.29%5.75B |
Operating expense | 14.74%4.83B | 13.15%4.71B | 20.46%4.36B | 22.60%16.25B | 23.24%4.03B | 23.29%4.21B | 25.77%4.17B | 17.69%3.62B | 1.42%13.26B | -4.43%3.27B |
Selling and administrative expenses | 16.40%2.1B | 10.67%2B | 12.41%1.84B | 14.40%6.94B | 15.15%1.46B | 11.75%1.8B | 18.23%1.81B | 11.53%1.63B | -1.21%6.07B | -16.39%1.27B |
-General and administrative expense | 16.40%2.1B | 10.67%2B | 12.41%1.84B | 14.40%6.94B | 15.15%1.46B | 11.75%1.8B | 18.23%1.81B | 11.53%1.63B | -1.21%6.07B | -16.39%1.27B |
Research and development costs | 13.49%2.73B | 15.05%2.71B | 27.09%2.52B | 29.52%9.31B | 28.40%2.56B | 33.62%2.41B | 32.25%2.36B | 23.29%1.99B | 3.75%7.19B | 5.14%2B |
Operating profit | 29.45%4.43B | 88.95%4.42B | 59.53%2.74B | 24.66%10.79B | 42.31%3.54B | 76.08%3.43B | 34.02%2.34B | -35.61%1.71B | 9.08%8.65B | -1.76%2.49B |
Net non-operating interest income expense | -91.41%-144.9M | -96.90%-146.3M | -95.04%-133.8M | -16.18%-312.3M | -60.17%-93.7M | -23.29%-75.7M | -4.65%-74.3M | 11.94%-68.6M | 14.50%-268.8M | 20.95%-58.5M |
Non-operating interest income | -2.25%47.8M | -18.91%37.3M | 33.92%45.8M | 176.43%173.6M | 74.51%44.5M | 143.28%48.9M | 350.98%46M | 388.57%34.2M | 147.24%62.8M | 244.59%25.5M |
Non-operating interest expense | 54.65%192.7M | 52.62%183.6M | 74.71%179.6M | 46.53%485.9M | 64.52%138.2M | 52.88%124.6M | 48.15%120.3M | 21.08%102.8M | -2.41%331.6M | 3.19%84M |
Other net income (expense) | 7.58%-2.7B | -330.94%-755M | 43.61%-65.7M | -148.43%-3.92B | -181.87%-937.5M | -817.61%-2.92B | 69.94%-175.2M | 78.09%-116.5M | -7.86%-1.58B | 46.19%-332.6M |
Gain on sale of security | 278.70%112.4M | -143.30%-157.9M | 216.79%16M | 95.08%-20.2M | -52.78%121.3M | 48.99%-62.9M | 45.42%-64.9M | 96.78%-13.7M | -332.17%-410.7M | 375.64%256.9M |
Special income (charges) | 2.26%-2.91B | -506.90%-589.3M | -5.24%-110.5M | -235.40%-3.87B | -148.13%-690.3M | -1,006.40%-2.98B | 77.95%-97.1M | 36.59%-105M | 31.83%-1.15B | 48.69%-278.2M |
-Less:Restructuring and merger&acquisition | ---- | ---- | ---- | 97.83%45.5M | ---- | ---- | ---- | ---- | 76.92%23M | ---- |
-Less:Impairment of capital assets | --81.6M | --435M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
-Less:Other special charges | -5.00%2.83B | 58.91%154.3M | 5.24%110.5M | 318.25%3.8B | 159.31%622.6M | 4,667.79%2.98B | -77.95%97.1M | -36.59%105M | -33.94%908.5M | -45.15%240.1M |
-Write off | ---- | ---- | ---- | -89.98%22.2M | ---- | ---- | ---- | ---- | -26.89%221.6M | ---- |
Other non- operating income (expenses) | -18.11%94.5M | 40.91%-7.8M | 1,209.09%28.8M | -128.67%-32.7M | -18.37%-368.5M | 56.58%115.4M | 44.07%-13.2M | -96.29%2.2M | -127.82%-14.3M | -1,899.42%-311.3M |
Income before tax | 271.82%1.59B | 68.38%3.52B | 65.79%2.54B | -3.70%6.55B | 19.67%2.51B | -72.71%427.2M | 91.48%2.09B | -25.51%1.53B | 10.57%6.81B | 13.94%2.1B |
Income tax | 27.55%618.1M | 68.93%550.2M | 58.66%293.2M | 134.01%1.31B | 101.07%319.1M | 325.83%484.6M | 135.33%325.7M | 22.63%184.8M | -2.13%561.6M | 39.46%158.7M |
Net income | 1,790.42%970.3M | 68.27%2.97B | 66.77%2.24B | -16.08%5.24B | 13.01%2.19B | -103.95%-57.4M | 85.11%1.76B | -29.32%1.34B | 11.88%6.24B | 12.26%1.94B |
Net income continuous Operations | 1,790.42%970.3M | 68.27%2.97B | 66.77%2.24B | -16.08%5.24B | 13.01%2.19B | -103.95%-57.4M | 85.11%1.76B | -29.32%1.34B | 11.88%6.24B | 12.26%1.94B |
Minority interest income | ||||||||||
Net income attributable to the parent company | 1,790.42%970.3M | 68.27%2.97B | 66.77%2.24B | -16.08%5.24B | 13.01%2.19B | -103.95%-57.4M | 85.11%1.76B | -29.32%1.34B | 11.88%6.24B | 12.26%1.94B |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 1,790.42%970.3M | 68.27%2.97B | 66.77%2.24B | -16.08%5.24B | 13.01%2.19B | -103.95%-57.4M | 85.11%1.76B | -29.32%1.34B | 11.88%6.24B | 12.26%1.94B |
Basic earnings per share | 1,900.00%1.08 | 67.86%3.29 | 67.11%2.49 | -16.02%5.82 | 19.38%2.4346 | -103.73%-0.06 | 84.91%1.96 | -29.38%1.49 | 12.68%6.93 | 12.67%2.0393 |
Diluted earnings per share | 1,883.33%1.07 | 68.21%3.28 | 66.44%2.48 | -15.94%5.8 | 18.67%2.42 | -103.73%-0.06 | 85.71%1.95 | -29.05%1.49 | 12.75%6.9 | 12.67%2.0393 |
Dividend per share | 15.04%1.3 | 15.04%1.3 | 15.04%1.3 | 15.31%4.52 | 15.31%1.13 | 15.31%1.13 | 15.31%1.13 | 15.31%1.13 | 15.29%3.92 | 15.29%0.98 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |